ÂÜÀòÂÒÂ×

Kevin Chih-Yuan Ho is currently an Investment Manager at Taiwania Capital. Prior to this, Kevin Chih-Yuan held the position of Director of Business and Clinical Development at Steminent Biotherapeutics Inc., a global biopharmaceutical company. Kevin Chih-Yuan has also served as the President of the National Taiwan University Alumni UK Association and gained experience as an Internship Trainee at SinoPac Securities. With a background in Biomedical Engineering, Kevin's expertise spans various industries including project consultancy in the construction sector and research assistance in a hospital setting.